Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

about

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome

P2860

Q58787070-EF4E0213-4414-4962-BF93-6817FD831FBF

P2860

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

Item

http://www.wikidata.org/entity/Q37665288

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Distinct mutation profile and ...... odysplastic syndromes (h-MDS).

@en

Distinct mutation profile and ...... stic myelodysplastic syndromes

@nl

type

Item

label

Distinct mutation profile and ...... odysplastic syndromes (h-MDS).

@en

Distinct mutation profile and ...... stic myelodysplastic syndromes

@nl

prefLabel

Distinct mutation profile and ...... odysplastic syndromes (h-MDS).

@en

Distinct mutation profile and ...... stic myelodysplastic syndromes

@nl

P1476

Distinct mutation profile and ...... odysplastic syndromes (h-MDS).

@en

P2093

Bor-Shen Ko

http://www.w3.org/2001/XMLSchema#string

Chi-Cheng Li

http://www.w3.org/2001/XMLSchema#string

Chi-Yuan Yao

http://www.w3.org/2001/XMLSchema#string

Chia-Wen Liu

http://www.w3.org/2001/XMLSchema#string

Chieh-Yu Liu

http://www.w3.org/2001/XMLSchema#string

Chien-Chin Lin

http://www.w3.org/2001/XMLSchema#string

Chien-Ting Lin

http://www.w3.org/2001/XMLSchema#string

Mei-Hsuan Tseng

http://www.w3.org/2001/XMLSchema#string

Ming Yao

http://www.w3.org/2001/XMLSchema#string

Ming-Chih Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.

Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS

Prognosis of myelodysplastic syndromes

International scoring system for evaluating prognosis in myelodysplastic syndromes

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Clinical effect of point mutations in myelodysplastic syndromes

Predicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score system

P304

63177-63188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11050

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27527853

http://www.w3.org/2001/XMLSchema#string

P932

5325355

http://www.w3.org/2001/XMLSchema#string

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

about

P2860

P2860

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932